Optimal anticoagulation prior to cath: Bivalirudin vs. Heparin the saga continues….

about

Optimal anticoagulation prior to cath: Bivalirudin vs. Heparin the saga continues….

Item

http://www.wikidata.org/entity/Q49114283

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Optimal anticoagulation prior to cath: Bivalirudin vs. Heparin the saga continues….

@en

Optimal anticoagulation prior to cath: Bivalirudin vs. Heparin the saga continues….

@nl

type

Item

label

Optimal anticoagulation prior to cath: Bivalirudin vs. Heparin the saga continues….

@en

Optimal anticoagulation prior to cath: Bivalirudin vs. Heparin the saga continues….

@nl

prefLabel

Optimal anticoagulation prior to cath: Bivalirudin vs. Heparin the saga continues….

@en

Optimal anticoagulation prior to cath: Bivalirudin vs. Heparin the saga continues….

@nl

P1476

Optimal anticoagulation prior to cath: Bivalirudin vs. Heparin the saga continues….

@en

P2093

Jorge A Belardi

http://www.w3.org/2001/XMLSchema#string

Mariano Albertal

http://www.w3.org/2001/XMLSchema#string

P2860

2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Bivalirudin for patients with acute coronary syndromes

Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: a pre-specified analysis from the EUROMA

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati

Impact of anticoagulation regimen prior to revascularization in patients with non-ST-segment elevation acute coronary syndromes: The ACUITY trial.

P304

182-183

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1002/CCD.26670

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27530189

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation